B
Beatriz Perez-Villamil
Researcher at Hospital Clínico San Carlos
Publications - 11
Citations - 3506
Beatriz Perez-Villamil is an academic researcher from Hospital Clínico San Carlos. The author has contributed to research in topics: Gene & Gene expression profiling. The author has an hindex of 5, co-authored 10 publications receiving 2497 citations.
Papers
More filters
Journal ArticleDOI
The consensus molecular subtypes of colorectal cancer
Justin Guinney,Rodrigo Dienstmann,Rodrigo Dienstmann,Xingwu Wang,Xingwu Wang,Aurélien de Reyniès,Andreas Schlicker,Charlotte Soneson,Laetitia Marisa,Paul Roepman,Gift Nyamundanda,Paolo Angelino,Brian M. Bot,Jeffrey S. Morris,Iris Simon,Sarah Gerster,Evelyn Fessler,Felipe De Sousa E Melo,Edoardo Missiaglia,Hena R. Ramay,David Barras,Krisztian Homicsko,Dipen M. Maru,Ganiraju C. Manyam,Bradley M. Broom,Valérie Boige,Beatriz Perez-Villamil,Ted Laderas,Ramon Salazar,Joe W. Gray,Douglas Hanahan,Josep Tabernero,René Bernards,Stephen H. Friend,Pierre Laurent-Puig,Jan Paul Medema,Anguraj Sadanandam,Lodewyk F. A. Wessels,Mauro Delorenzi,Mauro Delorenzi,Scott Kopetz,Louis Vermeulen,Sabine Tejpar +42 more
TL;DR: An international consortium dedicated to large-scale data sharing and analytics across expert groups is formed, showing marked interconnectivity between six independent classification systems coalescing into four consensus molecular subtypes (CMSs) with distinguishing features.
Journal ArticleDOI
Human dendritic cells activated with MV130 induce Th1, Th17 and IL-10 responses via RIPK2 and MyD88 signalling pathways.
Cristina Cirauqui,Cristina Benito-Villalvilla,Silvia Sánchez-Ramón,Sofía Sirvent,Carmen M. Diez-Rivero,Laura Conejero,Paola Brandi,Lourdes Hernández-Cillero,Juliana Lucía Ochoa,Beatriz Perez-Villamil,David Sancho,José Luis Subiza,José Luis Subiza,Oscar Palomares +13 more
TL;DR: It is shown that MV130 promotes the generation of Th1/Th17 responses via receptor‐interacting serine/threonine‐protein kinase‐2 (RIPK2)‐ and myeloid‐differentiation primary‐response gene‐88 (MyD88)‐mediated signalling pathways under the control of IL‐10, and elucidate immunological mechanisms underlying the potential way of action of MV130.
Journal ArticleDOI
SOD3 improves the tumor response to chemotherapy by stabilizing endothelial HIF-2α.
Emilia Mira,Lorena Carmona-Rodríguez,Beatriz Perez-Villamil,Josefina Casas,María Jesús Fernández-Aceñero,Diego Martínez-Rey,Paula Martin-Gonzalez,Ignacio Heras-Murillo,Mateo Paz-Cabezas,Manuel Tardaguila,Manuel Tardaguila,Tim D. Oury,Silvia Martin-Puig,Rosa Ana Lacalle,Gemma Fabriàs,Eduardo Díaz-Rubio,Santos Mañes +16 more
TL;DR: It is shown that specific SOD3 re-expression in tumor-associated endothelial cells (ECs) increases doxorubicin delivery into and chemotherapeutic effect on tumors, via the HIF-2a/VE-cadherin pathway.
Journal ArticleDOI
A 50-gene signature is a novel scoring system for tumor-infiltrating immune cells with strong correlation with clinical outcome of stage I/II non-small cell lung cancer.
S. Hernández-Prieto,A. Romera,M. Ferrer,J. L. Subiza,J.A. López-Asenjo,J.R. Jarabo,Ana Gómez,Elena M. Molina,Javier Puente,Jose-Luis Gonzalez-Larriba,Florentino Hernando,Beatriz Perez-Villamil,Eduardo Díaz-Rubio,Julian Sanz-Ortega +13 more
TL;DR: Favorable prognosis in completely resected NSCLC is determined by a B-cell-mediated immune response that can be differently scored by a 50-gene expression profile or by CD20 immunostaining, and may become a new tool for determining individualized adjuvant therapies.
Journal ArticleDOI
SOD3 induces a HIF-2α-dependent program in endothelial cells that provides a selective signal for tumor infiltration by T cells
Lorena Carmona-Rodríguez,Diego Martínez-Rey,María Jesús Fernández-Aceñero,Alicia Gonzalez-Martin,Mateo Paz-Cabezas,Noé Rodríguez-Rodríguez,Beatriz Perez-Villamil,María Eugenia Sáez,Eduardo Díaz-Rubio,Emilia Mira,Santos Mañes +10 more
TL;DR: The findings suggest that SOD3-induced upregulation of LAMA4 in endothelial cells boosts selective tumor infiltration by T lymphocytes, thus transforming immunologically “cold” into “hot” tumors.